
News|Articles|June 20, 2024
The Shift Toward Precision Medicine Requires Claims Data Insights
Author(s)PurpleLab
Healthcare today is evolving into precision medicine, or what the FDA refers to as personalized medicine. To stay competitive in the constantly shifting healthcare landscape, organizations across the healthcare ecosystem must embrace this targeted approach and leverage the tools needed to make safe decisions for their patients or populations. By unlocking insights provided from advanced claims data, precision medicine can assist clinicians, thereby reducing their educated guesses, improving patient outcomes, and making more informed decisions.
Trending on Applied Clinical Trials Online
1
AI-Enabled Sites and the Future of Trial Planning: Q&A with Liz Beatty, Inato
2
ACT Brief: CTTI Risk Myth-Busting, Hidden ePRO Exclusion Criteria, and Patient-Centered Care Models
3
Operational Pragmatism in ePRO-heavy trials
4
ACT Brief: Simplifying Trials Through Selective Safety Data, AI-Driven Site Partnerships, and Biopharma Strategic Pivots
5